News

Multiple Myeloma Market Size to Reach USD 46.94 Billion by 2032 | Immunotherapy, CAR-T, and Precision Medicine Lead Growth – SNS Insider
According to Research by SNS Insider, U.S. Multiple Myeloma Market is projected to reach USD 13.91 Billion by 2032, as novel drug classes, immunotherapies, and diagnostic advances reshape treatment ...
Melanoma Clinical Trials 2025: EMA, PDMA, FDA Approvals, Medication, Therapies, Treatment Market, Mechanism of Action, Route of Administration, and Companies b…
In June 2025, Iovance Biotherapeutics announced that the Journal of Clinical Oncology has published the final analysis from ...